New TB funding trends report finds that funding for TB research in 2020 reached only US$915 million – less than half of investment needed to end TB.
New York City/Geneva (December 9, 2021) – The new Tuberculosis Research Funding Trends, 2005–2020 report from Treatment Action Group (TAG) and the Stop TB Partnership finds that global funding for TB research totaled US$915 million in 2020 - less than half the goal of US$2 billion set forth by participating country governments at the 2018 United Nations High-Level Meeting on TB.
The report presents new data on 2020 funding for TB research and development (R&D) and analyzes trends in investment since 2005. Despite the toll TB takes around the world, TB funding has been flat since 2018, and in 2020 TB received less than 1% of the amount invested in COVID-19 R&D.
“The mobilization of over US$100 billion for COVID-19 research and development in the first 11 months of the pandemic shows us just how powerful a coordinated effort against a disease can be,” noted Dr. Lucica Ditiu, Executive Director of the Stop TB Partnership. “We can and must harness this impressive commitment to global health toward the fight to end TB.”
View the full Press Release announcing the report here.
Key Report Resources
- View the online Advocacy Toolkit featuring social media tiles, template tweets, and a template letter to send to political leaders.
- Visit the STBP report webpage here and the TAG report webpage here.
Source: Stop TB Partnership